エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/23 | 6,150 | 6,160 | 6,043 | 6,090 | -2 | ±0% | 641,600 |
| 2024/04/22 | 5,969 | 6,098 | 5,923 | 6,092 | +191 | +3.2% | 1,002,400 |
| 2024/04/19 | 5,800 | 5,920 | 5,795 | 5,901 | +77 | +1.3% | 1,410,700 |
| 2024/04/18 | 5,875 | 5,913 | 5,811 | 5,824 | -80 | -1.4% | 1,118,500 |
| 2024/04/17 | 6,037 | 6,040 | 5,901 | 5,904 | -148 | -2.4% | 1,041,800 |
| 2024/04/16 | 5,950 | 6,052 | 5,928 | 6,052 | +40 | +0.7% | 797,900 |
| 2024/04/15 | 5,971 | 6,026 | 5,928 | 6,012 | -29 | -0.5% | 648,000 |
| 2024/04/12 | 6,023 | 6,045 | 5,971 | 6,041 | +72 | +1.2% | 776,900 |
| 2024/04/11 | 5,950 | 6,004 | 5,923 | 5,969 | -49 | -0.8% | 754,600 |
| 2024/04/10 | 6,106 | 6,130 | 6,018 | 6,018 | -112 | -1.8% | 622,900 |
| 2024/04/09 | 6,143 | 6,143 | 6,066 | 6,130 | +11 | +0.2% | 765,600 |
| 2024/04/08 | 6,140 | 6,185 | 6,068 | 6,119 | +15 | +0.2% | 787,000 |
| 2024/04/05 | 6,013 | 6,104 | 5,985 | 6,104 | +58 | +1% | 894,500 |
| 2024/04/04 | 6,017 | 6,094 | 5,997 | 6,046 | +106 | +1.8% | 1,109,400 |
| 2024/04/03 | 6,050 | 6,050 | 5,885 | 5,940 | -150 | -2.5% | 1,885,100 |
| 2024/04/02 | 6,102 | 6,128 | 6,047 | 6,090 | +11 | +0.2% | 1,115,900 |
| 2024/04/01 | 6,250 | 6,283 | 6,079 | 6,079 | -137 | -2.2% | 1,099,500 |
| 2024/03/29 | 6,250 | 6,267 | 6,195 | 6,216 | -15 | -0.2% | 1,237,700 |
| 2024/03/28 | 6,345 | 6,350 | 6,221 | 6,231 | -169 | -2.6% | 1,040,200 |
| 2024/03/27 | 6,401 | 6,426 | 6,312 | 6,400 | +45 | +0.7% | 1,230,900 |
| 2024/03/26 | 6,280 | 6,374 | 6,237 | 6,355 | +58 | +0.9% | 998,900 |
| 2024/03/25 | 6,310 | 6,328 | 6,241 | 6,297 | -79 | -1.2% | 1,395,800 |
| 2024/03/22 | 6,413 | 6,441 | 6,341 | 6,376 | -25 | -0.4% | 949,300 |
| 2024/03/21 | 6,380 | 6,415 | 6,335 | 6,401 | +71 | +1.1% | 1,038,800 |
| 2024/03/19 | 6,388 | 6,397 | 6,265 | 6,330 | -117 | -1.8% | 1,349,200 |
| 2024/03/18 | 6,380 | 6,468 | 6,351 | 6,447 | +140 | +2.2% | 1,175,700 |
| 2024/03/15 | 6,227 | 6,331 | 6,185 | 6,307 | +59 | +0.9% | 1,181,600 |
| 2024/03/14 | 6,398 | 6,398 | 6,221 | 6,248 | -240 | -3.7% | 1,605,500 |
| 2024/03/13 | 6,449 | 6,549 | 6,432 | 6,488 | +12 | +0.2% | 1,638,600 |
| 2024/03/12 | 6,385 | 6,486 | 6,307 | 6,476 | +104 | +1.6% | 1,482,700 |
| 2024/03/11 | 6,383 | 6,522 | 6,312 | 6,372 | +72 | +1.1% | 2,730,200 |
| 2024/03/08 | 6,170 | 6,383 | 6,124 | 6,300 | +230 | +3.8% | 3,246,900 |
| 2024/03/07 | 6,100 | 6,137 | 6,031 | 6,070 | -22 | -0.4% | 2,069,900 |
| 2024/03/06 | 6,095 | 6,141 | 6,055 | 6,092 | -2 | ±0% | 1,419,700 |
| 2024/03/05 | 6,180 | 6,199 | 6,068 | 6,094 | -146 | -2.3% | 1,785,800 |
| 2024/03/04 | 6,248 | 6,288 | 6,191 | 6,240 | +29 | +0.5% | 1,209,800 |
| 2024/03/01 | 6,253 | 6,328 | 6,211 | 6,211 | -43 | -0.7% | 1,329,900 |
| 2024/02/29 | 6,281 | 6,290 | 6,213 | 6,254 | -62 | -1% | 1,387,200 |
| 2024/02/28 | 6,200 | 6,369 | 6,192 | 6,316 | +74 | +1.2% | 1,584,800 |
| 2024/02/27 | 6,219 | 6,267 | 6,186 | 6,242 | +3 | ±0% | 1,246,800 |
| 2024/02/26 | 6,141 | 6,283 | 6,140 | 6,239 | +80 | +1.3% | 1,465,300 |
| 2024/02/22 | 6,170 | 6,190 | 6,131 | 6,159 | -39 | -0.6% | 1,534,500 |
| 2024/02/21 | 6,268 | 6,272 | 6,166 | 6,198 | -70 | -1.1% | 1,541,900 |
| 2024/02/20 | 6,265 | 6,309 | 6,241 | 6,268 | -29 | -0.5% | 1,312,500 |
| 2024/02/19 | 6,414 | 6,420 | 6,277 | 6,297 | -130 | -2% | 1,229,100 |
| 2024/02/16 | 6,360 | 6,469 | 6,336 | 6,427 | +127 | +2% | 1,519,000 |
| 2024/02/15 | 6,494 | 6,521 | 6,262 | 6,300 | -254 | -3.9% | 2,284,900 |
| 2024/02/14 | 6,662 | 6,667 | 6,492 | 6,554 | -132 | -2% | 1,459,100 |
| 2024/02/13 | 6,600 | 6,694 | 6,566 | 6,686 | +80 | +1.2% | 1,701,500 |
| 2024/02/09 | 6,538 | 6,629 | 6,494 | 6,606 | +104 | +1.6% | 1,725,300 |
251～
300
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
